Urologia Internationalis

Papers
(The H4-Index of Urologia Internationalis is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma21
Optimizing Antibiotic Treatment for Urinary Tract Infections Secondary to Escherichia coli in Elderly Diabetic Patients: Considering Age and Blood Glucose Control19
Associations between Urinary Concentrations of Polycyclic Aromatic Hydrocarbons and Overactive Bladder in US Adults: Data from the National Health and Nutrition Examination Survey 2005–201616
Front & Back Matter15
Spinal Anesthesia versus General Anesthesia in the Endoscopic Management of Proximal Ureteral Stones: A Critical Evaluation Focusing on the Total Anesthesia Time15
Prospective Analysis of Versatility and User Satisfaction with a Novel Single-Use Cystoscope with Working Channel14
Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score14
Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort14
What Is the Interaction between Urine C-Reactive Protein, Prostatic Inflammation, and Doxazosin Treatment in Patients with Benign Prostatic Hyperplasia? A Pilot Study13
Continuous Intrarenal Pressure Monitoring during Endourological Procedures for Stone Disease: A Canary in the Coalmine for Optimizing Patient Safety13
Front & Back Matter13
The Change of Erectile Function Post Recovery from COVID-19 Infection12
Prediction of Clinically Significant Prostate Cancer Using Multiparametric MRI, Biparametric MRI, and Clinical Parameters12
Real-World Evidence of Tumor and Patient Characteristics and Survival with Avelumab Maintenance after Chemotherapy for Advanced and Metastatic Urothelial Carcinoma12
0.16162395477295